A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved ...

T cell therapy called AIC100, which targets the ICAM-1 protein, demonstrated encouraging responses and an acceptable safety ...

Stem cell-derived pancreatic islets are being studied as a rich transplantable source for insulin production, a therapeutic ...

Researchers sought to assess the access to CAR-T therapy for patients within community-based and transplant cell therapy networks.

Gene sequencing enabled researchers to identify the specific milk protein that triggered a patient’s eosinophilic esophagitis ...